Anixa Biosciences, Inc. (ANIX)
2.64
-0.03
(-1.12%)
USD |
NASDAQ |
Oct 19, 15:33
Anixa Biosciences Cash from Operations (Annual) : -7.173M for Oct. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| October 31, 2025 | -7.173M |
| October 31, 2024 | -7.335M |
| October 31, 2023 | -6.209M |
| October 31, 2022 | -6.492M |
| October 31, 2021 | -4.937M |
| October 31, 2020 | -6.176M |
| October 31, 2019 | -4.741M |
| October 31, 2018 | -4.273M |
| October 31, 2017 | -3.797M |
| October 31, 2016 | -3.382M |
| October 31, 2015 | 1.363M |
| October 31, 2014 | -2.379M |
| October 31, 2013 | -3.187M |
| October 31, 2012 | -3.141M |
| October 31, 2011 | -0.716M |
| October 31, 2010 | -2.406M |
| October 31, 2009 | -2.502M |
| October 31, 2008 | -0.9019M |
| Date | Value |
|---|---|
| October 31, 2007 | -2.397M |
| October 31, 2006 | -1.847M |
| October 31, 2005 | -1.720M |
| October 31, 2004 | -1.205M |
| October 31, 2003 | -0.9585M |
| October 31, 2002 | -0.4315M |
| October 31, 2001 | -0.7178M |
| October 31, 2000 | -4.841M |
| October 31, 1999 | -6.117M |
| October 31, 1998 | -7.736M |
| October 31, 1997 | -10.17M |
| October 31, 1996 | -4.179M |
| October 31, 1995 | -2.938M |
| October 31, 1994 | -3.618M |
| October 31, 1993 | -2.569M |
| October 31, 1992 | -1.699M |
| October 31, 1991 | -1.223M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |
| Sarepta Therapeutics, Inc. | -222.54M |
| Vicapsys Life Sciences, Inc. | -0.0215M |